9-116697564-G-A

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001365068.1(ASTN2):​c.2806+28207C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.012 in 762,702 control chromosomes in the GnomAD database, including 613 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.041 ( 417 hom., cov: 32)
Exomes 𝑓: 0.0048 ( 196 hom. )

Consequence

ASTN2
NM_001365068.1 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: 0.560

Publications

0 publications found
Variant links:
Genes affected
ASTN2 (HGNC:17021): (astrotactin 2) This gene encodes a protein that is expressed in the brain and may function in neuronal migration, based on functional studies of the related astrotactin 1 gene in human and mouse. A deletion at this locus has been associated with schizophrenia. Multiple transcript variants encoding different proteins have been found for this locus. [provided by RefSeq, May 2010]
TRIM32 (HGNC:16380): (tripartite motif containing 32) The protein encoded by this gene is a member of the tripartite motif (TRIM) family. The TRIM motif includes three zinc-binding domains, a RING, a B-box type 1 and a B-box type 2, and a coiled-coil region. The protein localizes to cytoplasmic bodies. The protein has also been localized to the nucleus, where it interacts with the activation domain of the HIV-1 Tat protein. The Tat protein activates transcription of HIV-1 genes. [provided by RefSeq, Jul 2008]
TRIM32 Gene-Disease associations (from GenCC):
  • autosomal recessive limb-girdle muscular dystrophy
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • autosomal recessive limb-girdle muscular dystrophy type 2H
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, G2P, Labcorp Genetics (formerly Invitae)
  • Bardet-Biedl syndrome 11
    Inheritance: AR Classification: STRONG, LIMITED Submitted by: G2P, Labcorp Genetics (formerly Invitae)
  • Bardet-Biedl syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.85).
BP6
Variant 9-116697564-G-A is Benign according to our data. Variant chr9-116697564-G-A is described in ClinVar as [Benign]. Clinvar id is 674433.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.139 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ASTN2NM_001365068.1 linkc.2806+28207C>T intron_variant Intron 16 of 22 ENST00000313400.9 NP_001351997.1
TRIM32NM_012210.4 linkc.-81-98G>A intron_variant Intron 1 of 1 ENST00000450136.2 NP_036342.2 Q13049A0A024R843

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ASTN2ENST00000313400.9 linkc.2806+28207C>T intron_variant Intron 16 of 22 5 NM_001365068.1 ENSP00000314038.4 O75129-1
TRIM32ENST00000450136.2 linkc.-81-98G>A intron_variant Intron 1 of 1 1 NM_012210.4 ENSP00000408292.1 Q13049

Frequencies

GnomAD3 genomes
AF:
0.0407
AC:
6197
AN:
152160
Hom.:
413
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.142
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0151
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00104
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00949
Gnomad NFE
AF:
0.000397
Gnomad OTH
AF:
0.0291
GnomAD4 exome
AF:
0.00478
AC:
2915
AN:
610424
Hom.:
196
Cov.:
8
AF XY:
0.00393
AC XY:
1242
AN XY:
316246
show subpopulations
African (AFR)
AF:
0.143
AC:
2237
AN:
15690
American (AMR)
AF:
0.00906
AC:
212
AN:
23390
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
15828
East Asian (EAS)
AF:
0.00
AC:
0
AN:
31490
South Asian (SAS)
AF:
0.000428
AC:
22
AN:
51446
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
29660
Middle Eastern (MID)
AF:
0.00774
AC:
18
AN:
2326
European-Non Finnish (NFE)
AF:
0.000203
AC:
83
AN:
409310
Other (OTH)
AF:
0.0110
AC:
343
AN:
31284
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.509
Heterozygous variant carriers
0
136
272
407
543
679
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
46
92
138
184
230
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0408
AC:
6216
AN:
152278
Hom.:
417
Cov.:
32
AF XY:
0.0397
AC XY:
2960
AN XY:
74478
show subpopulations
African (AFR)
AF:
0.142
AC:
5889
AN:
41516
American (AMR)
AF:
0.0151
AC:
231
AN:
15302
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5184
South Asian (SAS)
AF:
0.000829
AC:
4
AN:
4824
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10628
Middle Eastern (MID)
AF:
0.0136
AC:
4
AN:
294
European-Non Finnish (NFE)
AF:
0.000397
AC:
27
AN:
68030
Other (OTH)
AF:
0.0288
AC:
61
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
283
566
849
1132
1415
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
58
116
174
232
290
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0194
Hom.:
53
Bravo
AF:
0.0467
Asia WGS
AF:
0.00693
AC:
25
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Jun 16, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.85
CADD
Benign
7.2
DANN
Benign
0.55
PhyloP100
0.56
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs73515229; hg19: chr9-119459843; API